Author
Listed:
- S. Vanitha
- A. Vijaya Lakshmi
- Sagar Dakua
Abstract
The scientific landscape is being reshaped by emerging technologies and their cutting-edge applications superseded by the State-of-the-art techniques. One such technology revolutionizing the world is Artificial Intelligence (AI). It is a field that encompasses a wide array of computational approaches and algorithms capable of mimicking complex cognitive skills and functions of human. AI encompasses Machine Learning (ML), and ML encompasses Deep Learning (DL), whereas Next Generation Sequencing (NGS) gets benefitted from AI/ML/DL for data analysis. Machine learning has applications in both personalized medicine and gene editing. It can predict patient-specific treatment responses based on genomic data. Moreover, they are instrumental in optimizing gene editing technologies such as CRISPR-Cas9 by predicting on- and off-target effects in test datasets, thereby facilitating the design of guide RNAs (gRNAs) that minimize off-target activity. ML can also be applied to organoid technology. Organoids are three-dimensional structures, cultivated from stem cells, that aim to recreate the intricate cellular arrangements and 3D architectures characteristic of natural organs, there by simplifying the study of organ complexity. Next-generation sequencing (NGS), facilitates the simultaneous sequencing of millions of DNA fragments, as it plays a crucial role in deciphering the genetic heterogeneity of diseases. DL leverages AI to analyse healthcare data and drive improvements in patient care. By leveraging realworld data (RWD), AI can also streamline clinical research and bridge the gap between research and real-world practice. Deep learning models learn from real-world data, enabling them to recognize patterns and predict outcomes in similar real-world situations. AI, encompassing machine learning and deep learning, is transforming various fields, including healthcare, where it complements powerful tools like next-generation sequencing (NGS) to advance disease understanding, personalized medicine, and drug discovery, improving early detection and streamlining clinical research with real-world data.
Suggested Citation
S. Vanitha & A. Vijaya Lakshmi & Sagar Dakua, 2025.
"Artificial Intelligence in Life Sciences - The Next Frontier, Decoding the Secrets of Life,"
Convergence of Technology & Biology ─ Transforming Life Sciences, in: Malathi Varma & S.Parijatham Kanchana & G.Sony (ed.),Convergence of Technology & Biology ─ Transforming Life Sciences, chapter 7, pages 59-65,
Shanlax Publications.
Handle:
RePEc:dax:ctbtls:978-93-6163-763-6:p:59-65
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dax:ctbtls:978-93-6163-763-6:p:59-65. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: S.Lakshmanan (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.